Arbor Pharmaceuticals
http://arborpharma.com/We believe that our strongest asset is our people and have hired industry veterans with pharmaceutical knowledge and experience across most therapeutic areas encompassing all stages of development, manufacturing and commercialization. We have a strong emphasis on results and believe a key differentiation for us is our speed of execution in decision making and implementation.
Arbor is proud to be a corporate sponsor of a number of nonprofit organizations in our current therapeutic areas. We believe in being a good corporate citizen by doing our part to help associations and foundations that focus on funding discovery of new medicines or helping people afflicted by diseases that our products treat. The entire growing Arbor team is dedicated to creating value for our patients and shareholders by bringing improved medicines to the market with a focus on quality.y
Overview
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Kohlberg Kravis Roberts | kkr.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 25, 2021 | The godfather of direct-to-consumer, Warby Parker, proves why storefronts aren’t dead | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Direct-to-consumer companies are known for being digital first, launching their storefronts onlin... |
| Aug 14, 2017 | Term Sheet — Monday, August 14 | THE END OF FOUNDER-FRIENDLY Good morning. Below is my Boom With a View column from Fortune’s upcoming print edition. (See all past columns here.) Paid Content What you need to know about growing cyberattacks From ExtraHop Inside startup cir... |
| Nov 12, 2010 | Arbor Pharmaceuticals Completes $34.8M Financing | Arbor Pharmaceuticals, an Atlanta, GA-based specialty pharmaceutical company, completed a $34.8m financing. This included a $17.5m investment in the form of Series B Preferred Stock led by Signet Healthcare Partners, LLC. The remainder of t... |
Reviews 0
FAQ about Arbor Pharmaceuticals
When was Arbor Pharmaceuticals founded?
Arbor Pharmaceuticals was founded in 2006.
How much funding has Arbor Pharmaceuticals raised?
Arbor Pharmaceuticals has raised $34.8M in total across 1 funding round.
Who has invested in Arbor Pharmaceuticals?
Parsers VC lists 2 investors of Arbor Pharmaceuticals, among them Kohlberg Kravis Roberts.
What has the press written about Arbor Pharmaceuticals?
Parsers VC has collected 4 articles mentioning Arbor Pharmaceuticals, among them “The godfather of direct-to-consumer, Warby Parker, proves why storefronts aren’t dead” (Aug 25, 2021) and “Term Sheet — Monday, August 14” (Aug 14, 2017).
Is Arbor Pharmaceuticals still active?
Yes, Arbor Pharmaceuticals is active; its latest activity on Parsers VC dates from Aug 25, 2021.